ODDÍL B

Předchozí stránka

517.1	V08AB02	iohexol (koncentrace 180 mg l/ml, do 15 ml v ampuli včetně)	parent.	10	ML	184,90	K
517.2	V08AB02	iohexol (koncentrace 240 mg l/ml, nad 15 do 30 ml v ampuli včetně)	parent.	10	ML	159,40	K
517.3	V08AB02	iohexol (koncentrace 240 mg l/ml, do 15 ml v jedné ampuli včetně)	parent.	10	ML	220,90	K
517.4	V08AB02	iohexol (koncentrace 240 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	122,70	K
517.5	V08AB02	iohexol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně)	parent.	10	ML	185,50	K
517.6	V08AB02	iohexol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně)	parent.	10	ML	256,70	K
517.7	V08AB02	iohexol (koncentrace 300 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	142,65	K
517.8	V08AB02	iohexol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně)	parent.	10	ML	207,20	K
517.9	V08AB02	iohexol (koncentrace 350 mg l/ml, nad 50 ml v ampuli)	parent. 10		ML	159,40	K
517.10	V08AB03	kyselina ioxagliková (koncentrace 320 mg l/ml, do 30 ml v ampuli včetně)	parent.	10	ML	236,91	K

59545	HEXABRIX 320	inj sol 25x50ml	GUT	F
59544	HEXABRIX 320	inj sol 1x50ml	GUT	F

517.11	V08AB03	kyselina ioxagliková (koncentrace 320 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	186,90	K
517.12	V08AB04	iopamidol (koncentrace 200 mg l/ml, do 15 ml v ampuli včetně)	parent.	10	ML	242,54	K
517.13	V08AB04	iopamidol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně)	parent.	10	ML	299,78	K
517.14	V08AB04	iopamidol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně)	parent.	10	ML	185,92	K
517.15	V08AB04	iopamidol (koncentrace 300 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	169,67	K
517.16	V08AB04	iopamidol (koncentrace 370 mg l/ml, do 15 ml v ampuli včetně)	parent.	10	ML	365,98	K
517.17	V08AB04	iopamidol (koncentrace 370 mg l/ml, nad 15 do 30 ml v jedné ampuli včetně)	parent.	10	ML	224,93	K
517.18	V08AB04	iopamidol (koncentrace 370 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	181,10	K
517.19	V08AB05	iopromid (koncentrace 240 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	122,70	K
517.20	V08AB05	iopromid (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně)	parent.	10	ML	185,40	K
517.21	V08AB05	iopromid (koncentrace 300 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	142,60	K
517.22	V08AB05	iopromid (koncentrace 370 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	165,80	K
517.23	V08AB06	iotrolan (koncentrace 240 mg l/ml, do 15 ml v ampuli včetně)	parent.	10	ML	429,71	K/P
517.24	V08AB06	iotrolan (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně)	parent.	10	ML	534,28	K/P
517.25	V08AB07	ioversol (koncentrace 160 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	95,60	K
517.26	V08AB07	ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	122,70	K
517.27	V08AB07	ioversol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně)	parent.	10	ML	256,70	K
517.28	V08AB07	ioversol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně)	parent.	10	ML	185,40	K
517.29	V08AB07	ioversol (koncentrace 300 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	142,65	K
517.30	V08AB07	ioversol (koncentrace 320 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	149,50	K
517.31	V08AB07	ioversol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně)	parent.	10	ML	207,20	K
517.32	V08AB07	ioversol (koncentrace 350 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	159,42	K
517.33	V08AB09	iodixanol (koncentrace 150 mg l/ml, od 50 ml v jedné ampuli)	parent.	10	ML	215,46	K

42404	VISIPAQUE 150 MG l/ML	inj sol 10x50ml-amp	NYI	N
45114	VISIPAQUE 150MG l/ML	inj 10x50ml	NRI	IRL
45115	VISIPAQUE 150MG l/ML	inj 6x200ml	NRI	IRL
84340	VISIPAQUE 150MG l/ML	inj 6x200ml	NYI	N
84339	VISIPAQUE 150MG l/ML	inj 10x50ml	NYI	N
42405	VISIPAQUE 150 MG l/ML	inj sol 10x50ml-amp	NRI	IRL
42403	VISIPAQUE 150 MG l/ML	inj sol 10x200ml-pp	NRI	IRL
42402	VISIPAQUE 150 MG l/ML	inj sol 10x200ml-pp	NYI	N
42400	VISIPAQUE 150 MG l/ML	inj sol 10x100ml-pp	NYI	N
42399	VISIPAQUE 150 MG l/ML	inj sol 6x500ml-skl	NRI	IRL
42401	VISIPAQUE 150 MG l/ML	inj sol 10x100ml-pp	NRI	IRL
42398	VISIPAQUE 150 MG l/ML	inj sol 6x500ml-skl	NYI	N

517.34

V08AB09

iodixanol (koncentrace 270 mg l/ml, do 30 ml včetně v jedné ampuli)

parent.

10

ML

336,60

K

42420	VISIPAQUE 270 MG l/ML	inj sol 10x10ml-amp	NYI	N
42421	VISIPAQUE 270 MG l/ML	inj sol 10x10ml-amp	NRI	IRL
42422	VISIPAQUE 270 MG l/ML	inj sol 10x20ml-amp	NYI	N
84341	VISIPAQUE 270MG l/ML	inj 10x20ml	NYI	N
42423	VISIPAQUE 270 MG l/ML	inj sol 10x20ml-amp	NRI	IRL
45118	VISIPAQUE 270MG l/ML	inj 10x20ml	NRI	IRL

517.35

V08AB09

iodixanol (koncentrace 270 mg l/ml, od 50 ml v jedné ampuli)

parent.

10

ML

282,14

K

84342	VISIPAQUE 270MG l/ML	inj 10x50ml	NYI	N
42408	VISIPAQUE 270 MG l/ML	inj sol 10x75ml-pp	NYI	N
42407	VISIPAQUE 270 MG l/ML	inj sol 6x500ml-skl	NRI	IRL
45119	VISIPAQUE 270MG l/ML	inj 10x50ml	NRI	IRL
42406	VISIPAQUE 270 MG l/ML	inj sol 6x500ml-skl	NYI	N
45121	VISIPAQUE 270MG l/ML	inj 6x200ml	NRI	IRL
42411	VISIPAQUE 270 MG l/ML	inj sol 10x100ml-pp	NRI	IRL
45120	VISIPAQUE 270MG l/ML	inj 10x100ml	NRI	IRL
42410	VISIPAQUE 270 MG l/ML	inj sol 10x100ml-pp	NYI	N
42419	VISIPAQUE 270 MG l/ML	inj sol 6x500ml-pp	NRI	IRL
42418	VISIPAQUE 270 MG l/ML	inj sol 6x500ml-pp	NYI	N
42417	VISIPAQUE 270 MG l/ML	inj sol 10x200ml-pp	NRI	IRL
42416	VISIPAQUE 270 MG l/ML	inj sol 10x200ml-pp	NYI	N
42415	VISIPAQUE 270 MG l/ML	inj sol 10x175ml-pp	NRI	IRL
42427	VISIPAQUE 270 MG l/ML	inj sol 10x50ml-amp	NRI	IRL
42409	VISIPAQUE 270 MG l/ML	inj sol 10x75ml-pp	NRI	IRL
42424	VISIPAQUE 270 MG l/ML	inj sol 10x40ml-amp	NYI	N
42426	VISIPAQUE 270 MG l/ML	inj sol 10x50ml-amp	NYI	N
42414	VISIPAQUE 270 MG l/ML	inj sol 10x175ml-pp	NYI	N
42413	VISIPAQUE 270 MG l/ML	inj sol 10x150ml-pp	NRI	IRL
84344	VISIPAQUE 270MG l/ML	inj 6x200ml	NYI	N
84343	VISIPAQUE 270MG l/ML	inj 10x100ml	NYI	N
42412	VISIPAQUE 270 MG l/ML	inj sol 10x150ml-pp	NYI	N
42425	VISIPAQUE 270 MG l/ML	inj sol 10x40ml-amp	NRI	IRL

517.36

V08AB09

iodixanol (koncentrace 320 mg l/ml, do 30 ml včetně v jedné ampuli)

parent.

10

ML

357,46

K

42442	VISIPAQUE 320 MG l/ML	inj sol 10x10ml-amp	NYI	N
42444	VISIPAQUE 320 MG l/ML	inj sol 10x20ml-amp	NYI	N
45122	VISIPAQUE 320MG l/ML	inj 10x20ml	NRI	IRL
84345	VISIPAQUE 320MG l/ML	inj 10x20ml	NYI	N
42445	VISIPAQUE 320 MG l/ML	inj sol 10x20ml-amp	NRI	IRL
42443	VISIPAQUE 320 MG l/ML	inj sol 10x10ml-amp	NRI	IRL

517.37

V08AB09

iodixanol (koncentrace 320 mg l/ml, od 50 ml v jedné ampuli)

parent.

10

ML

287,25

K

84348	VISIPAQUE 320MG l/ML	inj 6x200ml	NYI	N
84346	VISIPAQUE 320MG l/ML	inj 10x50ml	NYI	N
84347	VISIPAQUE 320MG l/ML	inj 10x100ml	NYI	N
42440	VISIPAQUE 320 MG l/ML	inj sol 6x500ml-pp	NYI	N
42428	VISIPAQUE 320 MG l/ML	inj sol 6x500ml-skl	NYI	N
42429	VISIPAQUE 320 MG l/ML	inj sol 6x500ml-skl	NRI	IRL
42430	VISIPAQUE 320 MG l/ML	inj sol 10x75ml-pp	NYI	N
42431	VISIPAQUE 320 MG l/ML	inj sol 10x75ml-pp	NRI	IRL
42432	VISIPAQUE 320 MG l/ML	inj sol 10x100ml-pp	NYI	N
42433	VISIPAQUE 320 MG l/ML	inj sol 10x100ml-pp	NRI	IRL
42434	VISIPAQUE 320 MG l/ML	inj sol 10x150ml-pp	NYI	N
42435	VISIPAQUE 320 MG l/ML	inj sol 10x150ml-pp	NRI	IRL
42436	VISIPAQUE 320 MG l/ML	inj sol 10x175ml-pp	NYI	N
42437	VISIPAQUE 320 MG l/ML	inj sol 10x175ml-pp	NRI	IRL
42447	VISIPAQUE 320 MG l/ML	inj sol 10x40ml-amp	NRI	IRL
42439	VISIPAQUE 320 MG l/ML	inj sol 10x200ml-pp	NRI	IRL
42441	VISIPAQUE 320 MG l/ML	inj sol 6x500ml-pp	NRI	IRL
42446	VISIPAQUE 320 MG l/ML	inj sol 10x40ml-amp	NYI	N
42448	VISIPAQUE 320 MG l/ML	inj sol 10x50ml-amp	NYI	N
42449	VISIPAQUE 320 MG l/ML	inj sol 10x50ml-amp	NRI	IRL
45123	VISIPAQUE 320MG l/ML	inj 10x50ml	NRI	IRL
45124	VISIPAQUE 320MG l/ML	inj 10x100ml	NRI	IRL
45125	VISIPAQUE 320MG l/ML	inj 6x200ml	NRI	IRL
42438	VISIPAQUE 320 MG l/ML	inj sol 10x200ml-pp	NYI	N

517.38	V08AB10	iomeprol (koncentrace 150 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	92,70	K
517.39	V08AB10	iomeprol (koncentrace 200 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	109,70	K
517.40	V08AB10	iomeprol (koncentrace 250 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	126,00	K
517.41	V08AB10	iomeprol (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně)	parent.	10	ML	185,50	K
517.42	V08AB10	iomeprol (koncentrace 300 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	142,65	K
517.43	V08AB10	iomeprol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně)	parent.	10	ML	207,20	K
517.44	V08AB10	iomeprol (koncentrace 350 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	159,40	K
517.45	V08AB10	iomeprol (koncentrace 400 mg l/ml, do 30 ml v ampuli včetně)	parent.	10	ML	228,70	K
517.46	V08AB10	iomeprol (koncentrace 400 mg l/ml, nad 50 ml v ampuli)	parent.	10	ML	175,90	K
517.47	V08AB11	lobitridol (koncentrace 300 mg nad 50 ml v ampuli)	parent.	10	ML	142,65	K
517.48	V08AB11	lobitridol (koncentrace 350 mg nad 50 ml v ampuli)	parent.	10	ML	159,40	K

518

V08AC

rozpustné hepatotropní RTG kontrastní látky

parent.

K

518.1	V08AC	kyselina iodoxamová (koncentrace 183 mg l/ml)	parent.	10	ML	74,25	K
518.2	V08AC	kyselina iodoxamová (koncentrace 45 mg l/ml)	parent.	10	ML	37,39	K
518.3	V08AC04	adipiodon	parent.	10	ML	39,35	K

519

V08AD

nerozpustné RTG kontrastní látky

parent.

K

519.1	V08AD	iopydol + iopyron	parent.	10	ML	300,70	K
519.2	V08AD01	ethylestery jodovaných mastných kyselin	parent.	10	ML	462,54	K

59494

LIPIODOL ULTRA-FLUIDE

inj 1x10ml/4.8gm i

GUT

F

520

V08BA

RTG kontrastní přípravky obsahující síran barnatý

p.o.

K

520.1

V08BA01

síran barnatý

p.o.

100

GM

32,15

K

59062

MICROPAQUE

sus 1x2000ml

DEF

F

520.2

V08BA01

síran barnatý (lékové formy pro CT)

p.o.

7.5

GM

147,52

K

46675

MICROPAQUE CT

sus 1x2000ml/100gm

DEF

F

520.3	V08BA01	RTG kontrastní přípravky obsahující síran barnatý (lékové formy kolon)	p.rect.	100	GM	45,00	K
520.4	V08BA01	síran barnatý (lékové formy pasty)	p.o.	100	GM	94,58	K
520.5	V08BA01	síran barnatý (lékové formy HD)	p.o.	100	GM	36,73	K

59063

MICROPAQUE H.D. ORAL

plv 1x416gm

DEF

F

521

V08CA

paramagnetické kontrastní látky

parent.

K

521.1	V08CA01	dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně)	parent.	10	ML	1582,80	K
521.2	V08CA01	dimeglumin gadopentetat (nad 10 ml v 1 ampuli)	parent.	10	ML	1472,10	K
521.3	V08CA02	meglumin gadoterat do 10 ml v jedné ampuli včetně	parent.	10	ML	1582,80	K
521.4	V08CA02	meglumin gadoterat nad 10 ml v jedné ampuli	parent.	10	ML	1472,10	K
521.5	V08CA03	gadodiamid (do 10 ml v 1 ampuli včetně)	parent.	10	ML	1582,80	K
521.6	V08CA03	gadodiamid (nad 10 ml v 1 ampuli)	parent.	10	ML	1472,10	K
521.7	V08CA04	gadoteridol (do 10 ml v 1 ampuli včetně)	parent.	10	ML	1582,80	K
521.8	V08CA04	gadoteridol (nad 10 ml v 1 ampuli)	parent.	10	ML	1472,10	K
521.9	V08CA05	mangafodipir	parent.	10	ML	916,70	K
521.10	V08CA08	dimeglumin gadobenat (do 10 ml v 1 ampuli včetně)	parent.	10	ML	1582,80	K
521.11	V08CA08	dimeglumin gadobenat (nad 10 ml v 1 ampuli)	parent.	10	ML	1472,10	K
521.12	V08CA09	gadobutrol, koncentrace do 0,5 mmol/l včetně	parent.	10	ML	1472,10	K
521.13	V08CA09	gadobutrol, koncentrace nad 0,5 mmol/l	parent.	10	ML	2208,10	K
521.14	V08CB	ferucarbotran, s obsahem do 0,9 ml včetně	parent.	1	DF	5780,78	H
521.15	V08CB	ferucarbotran, s obsahem nad 0,9 ml	parent.	1	DF	6700,00	H
521.16	V08DA01	mikročástice albuminu s oktafluoropanem	parent.	1	DF	2857,50	H
521.17	V08DA02	mikročástice galaktózy	parent.	1	GM	914,00	H“.

Následující stránka